Uptake of genital mucosal sampling in HVTN 097, a phase 1b HIV vaccine trial in South Africa.
Because sexual transmission of HIV occurs across mucosal membranes, understanding the immune responses of the genital mucosa to vaccines may contribute knowledge to finding an effective candidate HIV vaccine. We describe the uptake of rectal secretion, cervical secretion and seminal mucosal secretio...
Main Authors: | Erica Maxine Lazarus, Kennedy Otwombe, Tania Adonis, Elaine Sebastian, Glenda Gray, Nicole Grunenberg, Surita Roux, Gavin Churchyard, Craig Innes, Fatima Laher |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4234370?pdf=render |
Similar Items
-
Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.
by: Kathryn L Hopkins, et al.
Published: (2014-01-01) -
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
by: Moodie Z, et al.
Published: (2009-10-01) -
HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials
by: Volk JE, et al.
Published: (2012-09-01) -
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator
by: Blattner William A
Published: (2005-12-01) -
P15-15. Advocates' perspectives on community engagement in the HVTN 505
by: Miller L, et al.
Published: (2009-10-01)